AJIC: American Journal of Infection Control
Volume 38, Issue 5, Supplement , Pages S25-S33 , June 2010

Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species

  • David J. Weber, MD, MPH

      Affiliations

    • Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • Department of Hospital Epidemiology, UNC Health Care, Chapel Hill, NC
    • Corresponding Author InformationAddress correspondence to David J. Weber, MD, MPH, 2163 Bioinformatics, CB 7030, Chapel Hill, NC 27599-7030.
    • ,
  • William A. Rutala, PhD, MPH

      Affiliations

    • Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • Department of Hospital Epidemiology, UNC Health Care, Chapel Hill, NC
    • ,
  • Melissa B. Miller, PhD

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • McLendon Laboratories, UNC Health Care, Chapel Hill, NC
    • ,
  • Kirk Huslage, RN, BSN, MSPH

      Affiliations

    • Department of Hospital Epidemiology, UNC Health Care, Chapel Hill, NC
    • ,
  • Emily Sickbert-Bennett, MS

      Affiliations

    • Department of Hospital Epidemiology, UNC Health Care, Chapel Hill, NC

References 

  1. Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollack DA, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep. 2007;122:160–166
  2. Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med. 1991;91(Suppl 3B):S179–S184
  3. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130
  4. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?. Clin Infect Dis. 2004;39:1182–1189
  5. Boyce J. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect. 2007;65:50–54
  6. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from room occupants. Arch Intern Med. 2006;166:1945–1951
  7. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in transmission of emerging healthcare-associated pathogens. In:  Rutala WA editors. Disinfection, sterilization, and antisepsis. Washington, DC: Association for Professionals in Infection Control and Epidemiology, Inc; 2010;
  8. Center for Disease Control and Prevention. Guideline for Hand Hygiene in Healthcare Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR. 2002;51(RR-16):1–44
  9. Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev. 2004;17:863–893
  10. Schulster LM, Chinn RYW, Arduino MJ, et al. Guidelines for environmental infection control in health-care facilities. Available from: http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Enviro_guide_03.pdf. Accessed January 2, 2010.
  11. Rutala WA, Weber DJ. Guideline for disinfection and sterilization in healthcare facilities, 2008. Available from: http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Disinfection_Nov_2008.pdf. Accessed January 2, 2010.
  12. Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect. 2009;73:378–385
  13. Goodman ER, Platt R, Bass R, et al. Impact of environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care units. Infect Control Hosp Epidemiol. 2008;29:593–599
  14. Hayden MK, Bonten MJM, Blom DW, Lyle EA, van de Vijver DAMC, Weinstein RA. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis. 2006;42:1552–1560
  15. Dancer SJ, White LF, Lamb J, Girvan EK, Robertson C. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med. 2009;7:28
  16. Atmar RL, Estes MK. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am. 2006;35:275–290
  17. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med. 2009;361:1776–1785
  18. Said MA, Perl TM, Sears CL. Gastrointestinal flu: norovirus in health care and long-term care facilities. Clin Infect Dis. 2008;47:1202–1208
  19. Greig JD, Lee MB. Enteric outbreak in long-term care facilities and recommendations for prevention: a review. Epidemiol Infect. 2009;137:145–155
  20. Harris JP, Lopman BA, O'Brien SJ. Infection control measures for norovirus: a systematic review of outbreaks in semi-enclosed settings. J Hosp Infect. 2010;74:1–9
  21. Hansen S, Stamm-Balderjahn S, Zuschneid I, et al. Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J Hosp Infect. 2007;65:348–353
  22. D'Souza DH, Sair A, Williams K, et al. Persistence of caliciviruses on environmental surfaces and their transfer to food. Int J Food Microbiol. 2006;108:84–91
  23. Clay S, Maherchandani S, Malik YS, Goyal SM. Survival on uncommon fomites of feline calicivirus, a surrogate of noroviruses. Am J Infect Control. 2006;34:41–43
  24. Lee J, Zoh K, Ko G. Inactivation and UV disinfection of murine norovirus with TiO2 under various environmental conditions. Appl Environ Microbiol. 2008;74:2111–2117
  25. Barker J, Vipond IB, Bloomfield SF. Effects of cleaning and disinfection in reducing the spread of norovirus contamination via environmental surfaces. J Hosp Infect. 2004;58:42–49
  26. Evans MR, Meldrum R, Lane W, et al. An outbreak of viral gastroenteritis following environmental contamination at a concert hall. Epidemiol Infect. 2002;129:355–360
  27. Estes MK, Prasad BVV, Atmar RL. Noroviruses everywhere: has something changed?. Curr Opin Infect Dis. 2006;19:467–474
  28. Gehrke C, Steinmann J, Goroncy-Bermes P. Inactivation of feline calicivirus, a surrogate of norovirus (formerly Norwalk-like viruses), by different types of alcohol in vitro and in vivo. J Hosp Infect. 2004;56:49–55
  29. Liu P, Yuen Y, Hsiao H-M, Jaykus L-A, Moe C. Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol. 2010;76:394–399
  30. Magulski T, Paulmann D, Bischoff B, et al. Inactivation of murine norovirus by chemical biocides on stainless steel. BMC Infect Dis. 2009;9:1–7
  31. Whitehead K, McCue KA. Virucidal efficacy of disinfectant actives against feline calicivirus, a surrogate for norovirus, in a short contact time. Am J Infect. 2010;38:26–30
  32. Malik YS, Maherchandani S, Goyal SM. Comparative efficacy of ethanol and isopropanol against feline calicivirus a norovirus surrogate. Am J Infect Control. 2006;34:31–35
  33. Jimenez L, Chiang M. Virucidal activity of a quaternary ammonium compound disinfectant against feline calicivirus: a surrogate for norovirus. Am J Infect Control. 2006;34:269–273
  34. Siegel JD, Rhinehart E, Jackson M, Chiarella L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Available from: http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf. Accessed January 2, 2010.
  35. Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med. 2002;346:334–339
  36. Kelly CP, LaMont JT. Clostridium difficile—more difficult than ever. N Engl J Med. 2008;359:1932–1940
  37. Gould CV, McDonald LC. Bench-to-bedside review: Clostridium difficile colitis. Crit Care. 2008;12:1–8
  38. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143:42–50
  39. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204–210
  40. Mutters R, Nonnenmacher C, Susin C, Albrecht U, Kropatsch R, Schumacher S. Quantitative detection of Clostridium difficile in hospital environmental samples by real-time polymerase chain reaction. J Hosp Infect. 2009;71:43–48
  41. Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med. 1996;100:32–40
  42. Fawley WN, Parnell P, Verity P, Freeman J, Wilcox MH. Molecular epidemiology of endemic Clostridium difficile infection and the significance of subtypes of the United Kingdom epidemic strain. J Clin Microbiol. 2005;43:2685–2696
  43. Shaughnessy M, Micielli R, Depestel D, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile associated diarrhea (CDAD), 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infections Disease Society of America. Washington, DC. Abstract K-4194, 2008.
  44. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freemen J. Comparison of the effect of detergent versus hypochlorite cleaning of environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect. 2003;54:109–114
  45. Boyce JM, Havill NL, Otter JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol. 2008;29:723–729
  46. Gerding DN, Muto CA, Owens RC. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl 1):43–49
  47. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(Suppl 1):S81–S92
  48. Vonberg RP, Kuijper EJ, Wilcox MH, et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect Dis. 2008;14:2–20
  49. Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD. Hang hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol. 2009;30:939–944
  50. Rupp ME, Fitzgerald T, Puumala S, et al. Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units. Infect Control Hosp Epidemiol. 2008;29:8–15
  51. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46:1254–1263
  52. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358:1271–1281
  53. Karageorgopoulos DE, Falagas M. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis. 2008;8:751–762
  54. Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997;35:1394–1397
  55. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol. 1998;36:1938–1941
  56. Catalano M, Quelle LS, Jeric PE, Martino A, Maimore SM. Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J Hosp Infect. 1999;42:27–35
  57. Musa EK, Desai N, Casewell MW. The survival of Acinetobacter calcoaceticus inoculated on fingertips and Formica. J Hosp Infect. 1990;15:219–227
  58. Markogiannakis A, Fildisis G, Tsiplakou S, et al. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit. Infect Control Hosp Epidemiol. 2008;29:410–417
  59. Rodriquez-Bano J, Garcia L, Ramirez E, et al. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach. Am J Infect Control. 2009;37:715–722
  60. Cardoso CL, Pereira HH, Zequim JC, Guihermetti M. Effectiveness of hand-cleansing agents for removing Acinetobacter baumannii strain from contaminated hands. Am J Infect Control. 1999;27:327–331

 STATEMENT OF CONFLICT OF INTEREST: Dr. Weber and Dr. Rutala have provided consultation for The Clorox Company and Johnson & Johnson. The remaining authors report no conflicts of interest.

 Publication of this article was made possible by unrestricted educational grants from The Clorox Company, the American Society for Healthcare Engineering, and the Facility Guidelines Institute.

PII: S0196-6553(10)00408-6

doi: 10.1016/j.ajic.2010.04.196

AJIC: American Journal of Infection Control
Volume 38, Issue 5, Supplement , Pages S25-S33 , June 2010

Article Tools